Low Fat-free Mass in Prognosis of People With Chronic Obstructive Pulmonary Disease

A new clinical trial registration (NCT07541053) for an observational study on low fat-free mass in COPD prognosis was published on ClinicalTrials.gov on April 21, 2026. The study will assess chronic obstructive pulmonary disease patients using multiple evaluation methods including the BODE index, GOLD ABE assessment (2024 criteria), spirometry, 6-minute walk test, and chest CT imaging.

This is a registry entry with no compliance implications. Clinical investigators and researchers studying COPD or pulmonary disease prognosis may monitor ClinicalTrials.gov for updates as the study progresses, but no regulatory action is required.